1. U.S. Department of Health and Human Services, “Steroid Receptors in Breast Cancer: Information for Physicians,” NIH Pub. No 83:1853 National Cancer Institute, Bethesda, August (1983).
2. Early breast cancer trialists collaborative group effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 38,896 women, N Engl J Med. 319: 1681 (1988).
3. T. Pomander, B. Cedarmark, A. Mattsson, L. Skoog, T. Theve, J. Askergrein, L.E. Rutqvist, U. Glas, C. Silversward, A. Somell, N. Wilking, and M.L. Hjalmar, Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers, Lancet. 1: 117 (1989).
4. D.T. Kiang, Chemoprevention for breast cancer: are we ready?, J Natl Cancer Inst. 83: 462 (1991).
5. J.W. Weisburger and E.L. Wynder, Dietary fat intake and cancer, Hematology/Oncology Clinics of North America. 5: 7 (1991).